12:00 AM
 | 
Jul 06, 2009
 |  BioCentury  |  Finance

2H09 Milestones

2H09 Milestones

Company Product Indication Event Milestone
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)/Biovail Corp. (TSX:BVF; NYSE:BVF) Pimavanserin tartrate (formerly ACP-103) Parkinson's disease psychosis (PDP) Ph III data 3Q09
Accentia Biopharmaceuticals Inc. (Pink:ABPIQ) Biovaxid Follicular non-Hodgkin's B cell lymphoma (NHL) Final Ph III data YE09
Acorda Therapeutics Inc. (NASDAQ:ACOR)/Elan Corp. plc (NYSE:ELN) Fampridine-SR Improve walking ability in people with multiple sclerosis (MS) PDUFA date 10/22/09
Acrux Ltd. (ASX:ACR) Axiron testosterone MD-Lotion Hypogonadism Submit NDA 2H09
Actelion Ltd. (SIX:ATLN) Pivlaz clazosentan Prevent cerebral vasospasm following aneurysmal subarachnoid hemorrhage (aSAH) Ph III data 2H09
Actelion Ltd. (SIX:ATLN) Tracleer bosentan (Ro 47-0203) Idiopathic pulmonary fibrosis (IPF) Final Ph III data 2H09
Actelion Ltd. (SIX:ATLN)/ GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) Orexin almorexant (formerly ACT-078573) Insomnia Ph III data 2H09
Advanced Life Sciences Holdings Inc. (OTCBB:ADLS)/Abbott Laboratories(NYSE:ABT)/Wyeth (NYSE:WYE) (A) Restanza cethromycin Community-acquired pneumonia (CAP) PDUFA date 7/31/09
Alkermes Inc. (NASDAQ:ALKS)/ Amylin Pharmaceuticals Inc. (NASDAQ:AMLN)/Eli Lilly and Co. (NYSE:LLY) Exenatide once weekly Type II diabetes Ph III data 3Q09
Allergan Inc. (NYSE:AGN) Botox botulinum toxin (BTX-A) Prevent headaches in patients with chronic migraine Final Ph III data; submit sBLA 2H09; mid-09
Allos Therapeutics Inc. (NASDAQ:ALTH) Pralatrexate (PDX) Relapsed or refractory peripheral T cell lymphoma (PTCL) PDUFA date 9/24/09
Amgen Inc. (NASDAQ:AMGN)/ Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) Prolia denosumab (AMG 162) Treat and prevent postmenopausal osteoporosis in women, and treat and prevent bone loss in patients undergoing hormone ablation for prostate or breast cancer PDUFA date 10/19/09
Amgen Inc. (NASDAQ:AMGN)/ Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) Prolia denosumab (AMG 162) Prevent skeletal-related events in patients with breast cancer and solid tumors Ph III data 2H09
Amgen Inc. (NASDAQ:AMGN)/ Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) Aranesp darbepoetin alfa Anemia in patients with chronic kidney disease (CKD) and Type II diabetes Ph III data 2H09
Amsterdam Molecular Therapeutics (Euronext:AMT) Glybera (AMT-011) (formerly AMT-010) Lipoprotein lipase (LPL) deficiency Submit MAA 2H09
Anika Therapeutics Inc. (NASDAQ:ANIK) Monovisc Pain caused by osteoarthritis (OA) of the knee Submit PMA YE09
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Lorcaserin (APD356) Obesity Ph III data; submit NDA September; YE09
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)/Merck & Co. Inc. (NYSE:MRK) Ridaforolimus (MK-8669) (formerly deforolimus) Metastatic soft tissue and bone sarcomas

Read the full 2717 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >